M. Pasquier

In Vivo and In Vitro Modulation of HLA-DM and HLA-DO Is Induced by B Lymphocyte Activation1

J. Trowsdale, J. Neefjes, M. V. van Ham, 2001, The Journal of Immunology.

Activationand HLA-DO Is Induced by B Lymphocyte In Vivo and In Vitro Modulation of HLA-DM

Marieke, J. Sotto, C. Roucard, 2001 .

Deciphering the fine nucleotide diversity of full HLA class I and class II genes in a well‐documented population from sub‐Saharan Africa

A. Langaney, A. Sanchez‐Mazas, M. Galan, 2017, HLA.

Resistance to CD95-mediated apoptosis through constitutive c-FLIP expression in a non-Hodgkin's lymphoma B cell line

J. Plumas, M. Jacob, J. Sotto, 2000, Leukemia.

Impairment of death‐inducing signalling complex formation in CD95‐resistant human primary lymphoma B cells

J. Plumas, D. Leroux, J. Sotto, 2004, British journal of haematology.

NF‐NF‐κBB‐dependent expression of the antiapoptotic factor c‐FLIP is regulated by calpain 3, the protein involved in limb‐girdle muscular dystrophy type 2A

Hanns Lochmuller, Gérard Lefranc, Isabelle Richard, 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Identification, characterisation and regulation by CD40 activation of novel CD95 splice variants in CD95-apoptosis-resistant, human, B-cell non-Hodgkin's lymphoma.

M. Callanan, R. Gressin, J. Plumas, 2009, Experimental cell research.